553 related articles for article (PubMed ID: 15910552)
1. SLE, atherosclerosis and cardiovascular disease.
Frostegård J
J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
[TBL] [Abstract][Full Text] [Related]
2. Atherosclerosis in patients with autoimmune disorders.
Frostegård J
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus erythematosus and cardiovascular disease.
Frostegård J
Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
[TBL] [Abstract][Full Text] [Related]
4. Annexin A5 in cardiovascular disease and systemic lupus erythematosus.
Cederholm A; Frostegård J
Immunobiology; 2005; 210(10):761-8. PubMed ID: 16325495
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
6. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
7. Peripheral vascular disease in antiphospholipid syndrome.
Vlachoyiannopoulos PG; Samarkos M
Thromb Res; 2004; 114(5-6):509-19. PubMed ID: 15507285
[TBL] [Abstract][Full Text] [Related]
8. Natural antibodies against phosphorylcholine in cardiovascular disease.
de Faire U; Frostegård J
Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
[TBL] [Abstract][Full Text] [Related]
9. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
10. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
[TBL] [Abstract][Full Text] [Related]
11. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
12. Cardiac manifestations in antiphospholipid syndrome.
Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
[TBL] [Abstract][Full Text] [Related]
13. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
Rhew EY; Ramsey-Goldman R
Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
[TBL] [Abstract][Full Text] [Related]
14. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
15. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
de Leeuw K; Kallenberg C; Bijl M
Ann N Y Acad Sci; 2005 Jun; 1051():362-71. PubMed ID: 16126978
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis in systemic lupus erythematosus.
Sherer Y; Zinger H; Shoenfeld Y
Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
[TBL] [Abstract][Full Text] [Related]
17. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Abou-Raya A; Abou-Raya S
Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
[TBL] [Abstract][Full Text] [Related]
18. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
Jara LJ; Medina G; Vera-Lastra O; Amigo MC
Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
[TBL] [Abstract][Full Text] [Related]
19. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
